Hematopathology Fellowship

血液病理学奖学金在吸引优秀申请者并为他们提供血液病理学培训方面非常成功，强调杰出的临床诊断，以及包括分子诊断和流式细胞术在内的专业诊断工具。自2000年以来，该奖学金已获得ACGME认证，毕业研究员在美国病理委员会进行的认证考试中有近100%的首次通过率。毕业生们在学术医学上建立了独立的职业生涯，包括近年来在莫菲特癌症中心、洛约拉大学、卫理公会医院（威尔康奈尔医学院）、加州大学戴维斯分校、梅奥诊所、纪念斯隆凯特琳癌症中心和克利夫兰诊所的任命。最近的两名毕业生成功地竞争了独立的NIH资助。鼓励研究员参与临床研究，并成功完成各种主题的研究，如下所述。艾伯利，宋金勇，奚丽丽，M. Raffeld， N. L. Harris， W. H. Wilson， S. Pittaluga， E. S. Jaffe（2012）。模拟经典霍奇金淋巴瘤的皮肤cd30阳性t细胞淋巴瘤累及淋巴结。中华外科杂志36(5):716- 725。Huppmann， A.， M. Roullet， M. Raffeld和E. Jaffe（出版中）。血管免疫母细胞t细胞淋巴瘤部分被ebv阴性克隆浆细胞增殖掩盖。临床肿瘤学杂志。Jegalian, a.g., f.c. Eberle, s.d. Pack， M. Mirvis， M. Raffeld， S. Pittaluga和E. S. Jaffe（2011）。滤泡性原位淋巴瘤：临床意义及与滤泡性淋巴瘤部分受累的比较。血液118(11):2976-84。Menon， M. P.， A. Jegalion， M. Raffeld， S. Pittaluga， L. Xi和E. S. Jaffe（2012）。原发性中枢神经系统t细胞淋巴瘤：临床、形态学、免疫表型和分子分析。现代病理学25:355A-355A。宋，J. Y.， T. Strom， M. Raffeld， S. Pittaluga和E. S. Jaffe（2011）。外周t细胞淋巴瘤伴CD30、CD15和CD20异常表达。J .临床肿瘤学。Summers, t.a., f.c. Eberle， S. Pittaluga, w.h. Wilson， K. Dunleavy， M. Raffeld， S. M. Hewitt和E. S. Jaffe（2011）。“灰色地带淋巴瘤：变得更加黑白分明。”24号直升机，补给1号。: 324。Summers, t.a.和e.s. Jaffe（2011）。毛细胞白血病诊断标准及鉴别诊断Leuk淋巴瘤。文卡塔拉曼，G.， K. A. Rizzo， J. J. Chavez， B. Streubel， M. Raffeld， E. S. Jaffe和S. Pittaluga（2011）。累及脑膜硬膜的边缘区淋巴瘤：可能与igg4相关疾病有关现代病理学杂志24(3):355-66。Venkataraman， G.， A. Traverse-Glehen， J. Y. Song， F. C. Eberle， J. C. Hanson， S. Dirnhofer， A. Tzankov， G. Heinze， M. A. Raffeld， S. Pittaluga和E. S. Jaffe（2011）。经典霍奇金淋巴瘤中异常t细胞抗原表达与无事件生存期（EFS）和总生存期（OS）降低相关。实验室调查91:326A-327A。

The Hematopathology Fellowship has been highly successful in attracting outstanding applicants and in providing them with training in hematopathology, emphasizing outstanding clinical diagnosis, and specialized diagnostic tools including molecular diagnostics and flow cytometry. The fellowship has been ACGME accredited since 2000, and graduating fellows have had a nearly a 100% first time pass rate on the accrediting examination given by the American Board of Pathology. Graduating fellows have gone on to establish independent careers in academic medicine, including appointments in recent years at the Moffit Cancer Center, Loyola University, The Methodist Hospital (Weill Cornell Medical School), The University of California -Davis, The Mayo Clinic, Memorial Sloan Kettering Cancer Center, and the Cleveland Clinic. Two of recent graduates have successfully competed for independent NIH funding. Fellows are encouraged to participate in clinical research, and have successfully completed studies on a variety of topics, as briefly mentioned below. Eberle, F. C., J. Y. Song, L. Xi, M. Raffeld, N. L. Harris, W. H. Wilson, S. Pittaluga and E. S. Jaffe (2012). "Nodal Involvement by Cutaneous CD30-positive T-cell Lymphoma Mimicking Classical Hodgkin Lymphoma." Am J Surg Pathol 36(5): 716-25.Huppmann, A., M. Roullet, M. Raffeld and E. Jaffe (in press ). "Angioimmunoblastic T-cell lymphoma partially obscured by an EBV-negative clonal plasma cell proliferation." Journal of Clinical Oncology.Jegalian, A. G., F. C. Eberle, S. D. Pack, M. Mirvis, M. Raffeld, S. Pittaluga and E. S. Jaffe (2011). "Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma." Blood 118(11): 2976-84.Menon, M. P., A. Jegalion, M. Raffeld, S. Pittaluga, L. Xi and E. S. Jaffe (2012). "Primary CNS T-Cell Lymphomas: Clinical, Morphologic, Immunophenotypic and Molecular Analysis." Modern Pathology 25: 355A-355A.Song, J. Y., T. Strom, M. Raffeld, S. Pittaluga and E. S. Jaffe (2011). "Peripheral T-Cell Lymphoma With Aberrant Expression of CD30, CD15, and CD20." J Clin Oncol.Summers, T. A., F. C. Eberle, S. Pittaluga, W. H. Wilson, K. Dunleavy, M. Raffeld, S. M. Hewitt and E. S. Jaffe (2011). "Gray zone lymphomas: becoming more black and white." Mod Pathol 24, Suppl 1.: 324A.Summers, T. A. and E. S. Jaffe (2011). "Hairy cell leukemia diagnostic criteria and differential diagnosis." Leuk Lymphoma.Venkataraman, G., K. A. Rizzo, J. J. Chavez, B. Streubel, M. Raffeld, E. S. Jaffe and S. Pittaluga (2011). "Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases." Mod Pathol 24(3): 355-66.Venkataraman, G., A. Traverse-Glehen, J. Y. Song, F. C. Eberle, J. C. Hanson, S. Dirnhofer, A. Tzankov, G. Heinze, M. A. Raffeld, S. Pittaluga and E. S. Jaffe (2011). "Aberrant T-Cell Antigen Expression in Classical Hodgkin Lymphoma Is Associated with Decreased Event-Free Survival (EFS) and Overall Survival (OS)." Laboratory Investigation 91: 326A-327A.